Literature DB >> 25125661

Transcriptional dynamics in colorectal carcinogenesis: new insights into the role of c-Myc and miR17 in benign to cancer transformation.

Eyal Ben-David1, Assaf C Bester2, Sagiv Shifman3, Batsheva Kerem1.   

Abstract

Colorectal cancer develops in a sequential, evolutionary process, leading to a heterogenic tumor. Comprehensive molecular studies of colorectal cancer have been previously performed; still, the process of carcinogenesis is not fully understood. We utilized gene expression patterns from 94 samples including normal, adenoma, and adenocarcinoma colon biopsies and performed a coexpression network analysis to determine gene expression trajectories of 8,000 genes across carcinogenesis. We found that the majority of gene expression changes occur in the transition from normal tissue to adenoma. The upregulated genes, known to be involved in cellular proliferation, included c-Myc along with its targets. In a cellular model system, we show that physiologic upregulation of c-Myc can lead to cellular proliferation without DNA replication stress. Our analysis also found that carcinogenesis involves a progressive downregulation of genes that are markers of colonic tissue and propose that this reflects a perturbed differentiation of colon cells during carcinogenesis. The analysis of miRNAs targets pointed toward the involvement of miR17 in the regulation of colon cell differentiation. Finally, we found that copy-number variations (CNV) enriched in colon adenocarcinoma tend to occur in genes whose expression changes already in adenoma, with deletions occurring in genes downregulated and duplications in genes upregulated in adenomas. We suggest that the CNVs are selected to reinforce changes in gene expression, rather than initiate them. Together, these findings shed new light into the molecular processes that underlie the transformation of colon tissue from normal to cancer and add a temporal context that has been hitherto lacking. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25125661     DOI: 10.1158/0008-5472.CAN-14-0932

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  The association between rs9642880 gene polymorphism and bladder cancer risk: a meta-analysis.

Authors:  Jingyuan Tang; Xiao Li; Xuping Jiang; Weizhang Xu; Zhen Xu; Wei Wang; Bianjiang Liu; Qiang Lv; Wei Zhang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  Comparison of biomarker expression between proximal and distal colorectal adenomas: The Tennessee-Indiana Adenoma Recurrence Study.

Authors:  Timothy Su; M Kay Washington; Reid M Ness; Douglas K Rex; Walter E Smalley; Thomas M Ulbright; Qiuyin Cai; Wei Zheng; Martha J Shrubsole
Journal:  Mol Carcinog       Date:  2016-08-11       Impact factor: 4.784

Review 3.  Transcription factors in colorectal cancer: molecular mechanism and therapeutic implications.

Authors:  Hui Xu; Lei Liu; Weilin Li; Duowu Zou; Jun Yu; Lifu Wang; Chi Chun Wong
Journal:  Oncogene       Date:  2020-12-15       Impact factor: 9.867

Review 4.  Targeting "undruggable" c-Myc protein by synthetic lethality.

Authors:  Chen Wang; Hui Fang; Jiawei Zhang; Ying Gu
Journal:  Front Med       Date:  2021-03-04       Impact factor: 4.592

5.  Molecular dissection of CRC primary tumors and their matched liver metastases reveals critical role of immune microenvironment, EMT and angiogenesis in cancer metastasis.

Authors:  Jiangang Liu; Yong Beom Cho; Hye Kyung Hong; Song Wu; Philip J Ebert; Steven M Bray; Swee Seong Wong; Jason C Ting; John N Calley; Catherine F Whittington; Shripad V Bhagwat; Christoph Reinhard; Robert Wild; Do-Hyun Nam; Amit Aggarwal; Woo Yong Lee; Sheng-Bin Peng
Journal:  Sci Rep       Date:  2020-07-01       Impact factor: 4.379

6.  Whole-exome sequencing of rectal cancer identifies locally recurrent mutations in the Wnt pathway.

Authors:  Yi Yang; Xiaodong Gu; Zhenyang Li; Chuang Zheng; Zihao Wang; Minwei Zhou; Zongyou Chen; Mengzhen Li; Dongbing Li; Jianbin Xiang
Journal:  Aging (Albany NY)       Date:  2021-10-12       Impact factor: 5.682

7.  Distribution of the c-MYC gene product in colorectal neoplasia.

Authors:  Ann-Marie Baker; Susan Van Noorden; Manuel Rodriguez-Justo; Patrizia Cohen; Nicholas A Wright; Irvin A Lampert
Journal:  Histopathology       Date:  2016-03-17       Impact factor: 5.087

8.  SEPT9 and SHOX2 DNA methylation status and its utility in the diagnosis of colonic adenomas and colorectal adenocarcinomas.

Authors:  Alexander Semaan; Anne van Ellen; Sebastian Meller; Dominik Bergheim; Vittorio Branchi; Philipp Lingohr; Diane Goltz; Jörg C Kalff; Glen Kristiansen; Hanno Matthaei; Dimitrios Pantelis; Dimo Dietrich
Journal:  Clin Epigenetics       Date:  2016-09-20       Impact factor: 6.551

9.  RNF8 induces β-catenin-mediated c-Myc expression and promotes colon cancer proliferation.

Authors:  Ling Ren; Tingting Zhou; Yang Wang; Yanmei Wu; Hongde Xu; Jingwei Liu; Xiang Dong; Fei Yi; Qiqiang Guo; Zhuo Wang; Xiaoman Li; Ning Bai; Wendong Guo; Min Guo; Bo Jiang; Xuan Wu; Yanling Feng; Xiaoyu Song; Siyi Zhang; Yue Zhao; Liu Cao; Shuai Han; Chengzhong Xing
Journal:  Int J Biol Sci       Date:  2020-05-01       Impact factor: 6.580

Review 10.  Alternative approaches to target Myc for cancer treatment.

Authors:  Chen Wang; Jiawei Zhang; Jie Yin; Yichao Gan; Senlin Xu; Ying Gu; Wendong Huang
Journal:  Signal Transduct Target Ther       Date:  2021-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.